BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16006193)

  • 1. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
    Muthumani K; Choo AY; Hwang DS; Dayes NS; Chattergoon M; Mayilvahanan S; Thieu KP; Buckley PT; Emmanuel J; Premkumar A; Weiner DB
    Mol Ther; 2005 Nov; 12(5):910-21. PubMed ID: 16006193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene.
    Yasuda J; Miyao T; Kamata M; Aida Y; Iwakura Y
    Virology; 2001 Jul; 285(2):181-92. PubMed ID: 11437653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.
    Muthumani K; Choo AY; Premkumar A; Hwang DS; Thieu KP; Desai BM; Weiner DB
    Cell Death Differ; 2005 Aug; 12 Suppl 1():962-70. PubMed ID: 15832179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function.
    Venkatachari NJ; Majumder B; Ayyavoo V
    Virology; 2007 Feb; 358(2):347-56. PubMed ID: 17023015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
    Fakruddin JM; Laurence J
    Arch Virol; 2005 Jan; 150(1):67-78. PubMed ID: 15449141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R.
    Zelivianski S; Liang D; Chen M; Mirkin BL; Zhao RY
    Apoptosis; 2006 Mar; 11(3):377-88. PubMed ID: 16520893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function.
    Muthumani K; Hwang DS; Dayes NS; Kim JJ; Weiner DB
    DNA Cell Biol; 2002 Sep; 21(9):689-95. PubMed ID: 12396612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
    Janoo A; Morrow PW; Tung HY
    J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H; McMillan JR
    FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.
    Muthumani K; Hwang DS; Choo AY; Mayilvahanan S; Dayes NS; Thieu KP; Weiner DB
    Int Immunol; 2005 Feb; 17(2):103-16. PubMed ID: 15611322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
    McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
    Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator.
    Sabbah EN; Druillennec S; Morellet N; Bouaziz S; Kroemer G; Roques BP
    Chem Biol Drug Des; 2006 Feb; 67(2):145-54. PubMed ID: 16492162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain.
    Acharjee S; Noorbakhsh F; Stemkowski PL; Olechowski C; Cohen EA; Ballanyi K; Kerr B; Pardo C; Smith PA; Power C
    FASEB J; 2010 Nov; 24(11):4343-53. PubMed ID: 20628092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of HIV-1 viral protein R-induced apoptosis.
    Muthumani K; Choo AY; Hwang DS; Chattergoon MA; Dayes NN; Zhang D; Lee MD; Duvvuri U; Weiner DB
    Biochem Biophys Res Commun; 2003 May; 304(3):583-92. PubMed ID: 12729593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
    Vlahakis SR; Bren GD; Algeciras-Schimnich A; Trushin SA; Schnepple DJ; Badley AD
    Clin Pharmacol Ther; 2007 Sep; 82(3):294-9. PubMed ID: 17361127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
    Zhou W; Blackwell TS; Goleniewska K; O'Neal JF; Fitzgerald GA; Lucitt M; Breyer RM; Peebles RS
    J Leukoc Biol; 2007 Mar; 81(3):809-17. PubMed ID: 17135575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells.
    Moon HS; Yang JS
    Mol Cells; 2006 Feb; 21(1):7-20. PubMed ID: 16511342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.
    Yedavalli VS; Shih HM; Chiang YP; Lu CY; Chang LY; Chen MY; Chuang CY; Dayton AI; Jeang KT; Huang LM
    J Virol; 2005 Nov; 79(21):13735-46. PubMed ID: 16227293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.